Novo Nordisk’s Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide: Study Read more
GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData Read more
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in 2023: GlobalData Read more